TerminatedPhase 3NCT05158699
Effectiveness of Periocular Drug Injection in CATaract Surgery
Studying Cystoid macular dystrophy
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Luigi Rondas
- Principal Investigator
- Nienke Visser, Dr.Universiteitskliniek voor Oogheelkunde Maastricht UMC+
- Intervention
- Bromfenac(drug)
- Enrollment
- 628 enrolled
- Eligibility
- 21 years · All sexes
- Timeline
- 2021 – 2024
Study locations (10)
- Hospital of the Brothers of Saint John of God, Vienna, Austria
- Vienna Institute for Research in Ocular Surgery, Hanusch Krankenhaus, Vienna, Austria
- Goethe University, Frankfurt am Main, Germany
- Amphia, Breda, Netherlands
- Deventer Ziekenhuis, Deventer, Netherlands
- Zuyderland Medisch Centrum, Heerlen, Netherlands
- University Eye Clinic Maastricht UMC+, Maastricht, Netherlands
- Canisius Wilhelmina Ziekenhuis Nijmegen, Nijmegen, Netherlands
- Elisabeth-Twee Steden Ziekenhuis, locatie Elisabeth, Tilburg, Netherlands
- University Hospital Coimbra, Coimbra, Portugal
Collaborators
European Society of Cataract and Refractive Surgeons
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT05158699 on ClinicalTrials.govOther trials for Cystoid macular dystrophy
Additional recruiting or active studies for the same condition.